These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6183554)

  • 21. Effects of subchronic haloperidol and sulpiride on regional brain dopamine metabolism in the rat.
    Lindefors N; Sharp T; Ungerstedt U
    Eur J Pharmacol; 1986 Oct; 129(3):401-4. PubMed ID: 3780852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of acute administration of the 5-HT1A receptor ligand, lesopitron, on rat cortical 5-HT and dopamine turnover.
    Ballarín M; Carceller A; Guitart X
    Br J Pharmacol; 1994 Oct; 113(2):425-30. PubMed ID: 7530571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of chloral hydrate, gamma-butyrolactone, and equithesin on the efflux of dopamine and 5-hydroxytryptamine metabolites into cerebroventricular perfusates of rats.
    Nielsen JA; Moore KE
    J Neurochem; 1982 Jul; 39(1):235-8. PubMed ID: 6177832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats.
    Mendelsohn FA; Jenkins TA; Berkovic SF
    Brain Res; 1993 Jun; 613(2):221-9. PubMed ID: 7514480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
    Meltzer HY; Chai BL; Thompson PA; Yamamoto BK
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The concentration of dopamine, 5-hydroxytryptamine, and some of their acid metabolites in the brain of genetically diabetic rats.
    Kwok RP; Walls EK; Juorio AV
    Neurochem Res; 1985 May; 10(5):611-6. PubMed ID: 2409457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing.
    Csernansky JG; Bellows EP; Barnes DE; Lombrozo L
    Psychopharmacology (Berl); 1990; 101(4):519-24. PubMed ID: 2388975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electroconvulsive shock produces large increases in interstitial concentrations of dopamine in the rat striatum: an in vivo microdialysis study.
    Nomikos GG; Zis AP; Damsma G; Fibiger HC
    Neuropsychopharmacology; 1991 Jan; 4(1):65-9. PubMed ID: 1706182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of dopamine-containing amacrine cells of retina: light-induced increase of acidic dopamine metabolites.
    Cohen J; Hadjiconstantinou M; Neff NH
    Brain Res; 1983 Jan; 260(1):125-7. PubMed ID: 6297678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of drug-induced changes in dopamine and serotonin metabolite concentrations in the CSF of the rat.
    Mignot E; Laude D; Elghozi JL
    J Neurochem; 1984 Mar; 42(3):819-25. PubMed ID: 6198472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine and serotonin metabolites in rat cerebroventricular fluid following withdrawal of haloperidol or electroshock treatment.
    Barkai AI; Kowalik S; Reches A
    Psychopharmacology (Berl); 1984; 84(3):352-5. PubMed ID: 6083575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of dopamine turnover by monitoring the decline of dopamine metabolites in rat CSF after alpha-methyl-p-tyrosine.
    Mignot E; Laude D
    J Neurochem; 1985 Nov; 45(5):1527-33. PubMed ID: 2864397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ontogeny of tolerance to haloperidol: behavioral and biochemical measures.
    Coyle S; Napier TC; Breese GR
    Brain Res; 1985 Nov; 355(1):27-38. PubMed ID: 4075104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of haloperidol-induced dopamine release in the rat striatum using intracerebral dialysis.
    Walters DE; Chapman CD; Howard SG
    J Neurochem; 1990 Jan; 54(1):181-6. PubMed ID: 2293609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Choline and physostigmine enhance haloperidol-induced HVA and DOPAC accumulation.
    Millington WR; Wurtman RJ
    Eur J Pharmacol; 1982 Jun; 80(4):431-4. PubMed ID: 7106193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
    Kato T; Dong B; Ishii K; Kinemuchi H
    J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interrelationships between plasma homovanillic acid and indices of dopamine turnover in multiple brain areas during haloperidol and saline administration.
    Csernansky JG; Barnes DE; Bellows EP; Lombrozo L
    Life Sci; 1990; 46(10):707-13. PubMed ID: 2314192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism.
    Gray AM; Connick JH
    Eur J Pharmacol; 1998 Dec; 362(2-3):127-36. PubMed ID: 9874162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats.
    Enrico P; Mura MA; Esposito G; Serra P; Migheli R; De Natale G; Desole MS; Miele M; Miele E
    Brain Res; 1998 Jun; 797(1):94-102. PubMed ID: 9630540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.